Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SUN PHARMACEUTICAL INDUSTRIES LTD. et al v. LUPIN LIMITED et al
Case Number:
3:18-cv-02213
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
February 08, 2022
Sun Pharma, Lupin Agree To Drop Eye Pain Patent Dispute
Sun Pharma on Tuesday agreed to drop a patent lawsuit against rival Lupin Pharmaceuticals over a branded treatment to prevent pain from eye surgery, while getting a New Jersey federal judge to toss an earlier ruling that invalidated Sun's patent at the heart of the case.
-
September 30, 2021
Sun Pharma's Eye Pain Patent Invalidated
A New Jersey federal judge has invalidated a Sun Pharma patent on a branded treatment to prevent pain in eye surgery patients, finding on Thursday that the patent was obvious in light of an earlier patent.